07 Jan 2001

Parfenac® Creme; (Parfenac® Creme) - Deutschland

Updated: 07 Jan 2001

Parfenac® Creme; -Fettsalbe; -Salbe

Creme/Salbe: Milderung v. Entzünd.symptomen b. endogenem Ekzem, Neurodermitis u. chron. Ekzemen. Fettsalbe: Ekzeme, Dermatitiden, z. B. Stauungsdermatitis, Kontaktdermatitis, Neurodermitis.

Parfenac® Creme; Description, Presentation and Dosage

Parfenac® Creme; Description

Parfenac® Creme; Drug Class Description

Einzelstoffe

Parfenac® Creme; Drug Description

1 g enth.: Bufexamac 50 mg.

Parfenac® Creme; Generic Name

Parfenac® Creme

Parfenac® Creme; Presentation

Parfenac® Creme; Presentation

Parfenac® Creme; -Fettsalbe; -Salbe

Parfenac® Creme; Manufacturer

Lederle

Related Learning Zones

COPD Knowledge Centre

COPD Knowledge Centre

The COPD Knowledge Centre has been designed to provide healthcare professionals with free access to educational materials and disease awareness information. This includes information on the epidemiology, pathophysiology and symptoms of COPD and the latest guidelines for the diagnosis, treatment and management of the disease.

COPD-specific resources such as videosguidelinesinfographics, materials for your patients, upcoming events, useful websites and symposium videos and materials from ATS 2015 are available free of charge.

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Parfenac® Creme; Dosage

Parfenac® Creme; Adult Dosage

Macrogolstearat 1000, Cetylstearylalkohol, Isopropylpalmitat, Glycerolmonostearat, Macrogol-[100]-(Mono,Di)Stearat, Benzylalkohol, Glycerol, Sorbitol, Milchsäure, gereinigtes Wasser. dioleat, Isopropylmyristat, Magnesiumsulfat, gereinigtes Wasser.

Parfenac® Creme; Child Dosage


Parfenac® Fettsalbe
Zus.: 1 g enth.: Bufexamac 50 mg.
Weit. Bestandteile: Macrogolstearat 1000-Cetylstearylalkohol, Propylenglycol, weißes Vaselin.

Parfenac® Salbe
Zus.: 1 g enth.: Bufexamac 50 mg.
Weit. Bestandteile: Aluminiumstearat, dünnflüssiges Paraffin, Hartparaffin, Wollwachsalkohole, mikrokristalline Kohlenwasserstoffe, weißes Vaselin, Glycerinmono- u. -

Parfenac® Creme; Precautions, Reactions and Contraindications

Parfenac® Creme; Special Precautions

Parfenac® Creme; Adverse Reactions

Parfenac® Creme; Adverse Reactions

Strenge Ind.-Stellung (keine klin. Erfahrg.). Nicht mehr als 10 g tgl.

Related Drugs - Dermatology

Back to top